Antoine Italiano

Antoine Italiano

Antoine Italiano , MD, PhD, is a renowned medical oncologist specializing in early drug development and precision medicine. He serves as Head of the Department of Medicine at Institut Bergonié in Bordeaux and leads the Precision Medicine program at Gustave Roussy in Paris. Prof. Italiano has been the Principal Investigator for over 50 Phase I trials and more than 40 Phase II and III trials in the past five years. His research focuses on immuno-oncology, targeted therapies, and translational research, particularly in rare tumors like sarcomas.

He earned his PhD in Molecular Cell Biology in 2008 and completed a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center in New York.

Prof. Italiano is a member of ASCO, AACR, and ESMO, and regularly reviews for top oncology journals. He has authored or co-authored over 500 peer-reviewed publications, including in Nature Medicine, Lancet Oncology, and JAMA Oncology.

He coordinates the CONDOR project, which combines precision medicine and immunotherapy to improve outcomes for metastatic sarcoma patients. Prof. Italiano is also involved in the Multipli study, part of France’s Genomic Medicine 2025 plan, aiming to expand genomic testing in cancer care.

His work has significantly shaped the field of precision oncology, bridging clinical gaps and driving therapeutic innovation.